OUTHIGH SIGNALFINANCIAL10-K

OUT experienced a meaningful decline in profitability with net income falling 43% and operating income down 31% year-over-year, while interest expenses increased substantially.

The significant deterioration in earnings performance raises questions about the company's operational efficiency and capital allocation strategy. The combination of reduced profitability and higher interest costs suggests either challenging market conditions or internal execution issues that require management attention and investor monitoring.

Comparing 2026-02-26 vs 2025-02-28View on EDGAR →
FINANCIAL ANALYSIS

OUT's financial performance weakened considerably with both net income and operating income declining meaningfully year-over-year, while interest expenses rose over 20% indicating higher debt service costs. The company did show growth in current assets and accounts receivable, suggesting potential revenue timing differences or collection challenges. Overall, the financial picture reveals a company facing profitability pressures despite maintaining operational scale.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
-43.1%
$258.2M→$147.0M

Net income declined 43.1% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-31%
$425.5M→$293.5M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Current Assets
Balance Sheet
+30.6%
$385.8M→$503.7M

Current assets grew 30.6% — improving short-term liquidity or inventory/receivables build.

Interest Expense
P&L
+20.2%
$131.8M→$158.4M

Interest costs rose 20.2% — monitor debt levels and coverage ratio in rising rate environment.

Accounts Receivable
Balance Sheet
+19.8%
$305.3M→$365.7M

Receivables grew 19.8% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-28
ADDED
), enabling advertisers to engage with audiences in high-impact in-real-life ( IRL ) moments and environments.
In total, we have displays in approximately 120 markets across the U.S., including the 25 largest markets in the U.S.
Our top market, location-focused portfolio includes sites in and around New York City, Los Angeles and San Francisco, where public spaces can turn into platforms for creativity, connection and cultural relevance.
The breadth and depth of our portfolio provides our customers with a range of options to address their marketing objectives by elevating brand influence and credibility through enterprise or commercial brand-building campaigns.
We believe the continued evolution of out-of-home advertising audience measurement systems, including Geopath and alternative measurement systems, can enhance the value of the out-of-home medium, including transit inventory, by improving audience measurement and enabling more precise demographic and location-based targeting.
+7 more — sign up free →
REMOVED
In total, we have displays in all of the 25 largest markets in the U.S.
Our top market, high-profile, location-focused portfolio includes sites in and around both Grand Central Station and Times Square in New York, various locations along Sunset Boulevard in Los Angeles, and the Bay Bridge in San Francisco.
The breadth and depth of our portfolio provides our customers with a range of options to address their marketing objectives, from national, brand-building campaigns to hyper-local campaigns that drive customers to the advertiser s website or retail location one mile down the road.
Geopath, the out-of-home advertising industry s audience measurement system, enables us to build campaigns based on the size and demographic composition of audiences.
As part of our technology platform, we are developing solutions for enhanced demographic and location targeting, and engaging ways to connect with consumers on-the-go.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →